{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T17:17:51Z","timestamp":1785777471128,"version":"3.56.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,2,20]],"date-time":"2017-02-20T00:00:00Z","timestamp":1487548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,2,20]],"date-time":"2017-02-20T00:00:00Z","timestamp":1487548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1038\/bmt.2017.5","type":"journal-article","created":{"date-parts":[[2017,2,20]],"date-time":"2017-02-20T14:42:26Z","timestamp":1487601746000},"page":"846-853","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Changes in the incidence, patterns and outcomes of graft failure following hematopoietic stem cell transplantation for Hurler syndrome"],"prefix":"10.1038","volume":"52","author":[{"given":"S H","family":"Lum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W P","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Poulton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Ogden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Logan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Bonney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T C","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P J","family":"Orchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R F","family":"Wynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,20]]},"reference":[{"key":"BFbmt20175_CR1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/jama.281.3.249","volume":"281","author":"PJ Meikle","year":"1999","unstructured":"Meikle PJ, Hopwood JJ, Clague AE, Carey WF . Prevalence of lysosomal storage disorders. JAMA 1999; 281: 249\u2013254.","journal-title":"JAMA"},{"key":"BFbmt20175_CR2","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1073\/pnas.64.1.360","volume":"64","author":"JC Fratantoni","year":"1969","unstructured":"Fratantoni JC, Hall CW, Neufeld EF . The defect in Hurler and Hunter syndromes. II. Deficiency of specific factors involved in mucopolysaccharide degradation. Proc Natl Acad Sci USA 1969; 64: 360\u2013366.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbmt20175_CR3","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1126\/science.162.3853.570","volume":"162","author":"JC Fratantoni","year":"1968","unstructured":"Fratantoni JC, Hall CW, Neufeld EF . Hurler and Hunter syndromes: mutual correction of the defect in cultured fibroblasts. Science 1968; 162: 570\u2013572.","journal-title":"Science"},{"key":"BFbmt20175_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/ajmg.1320460222","volume":"46","author":"CB Whitley","year":"1993","unstructured":"Whitley CB, Belani KG, Chang PN, Summers CG, Blazar BR, Tsai MY et al. Long-term outcome of Hurler syndrome following bone marrow transplantation. Am J Med Genet 1993; 46: 209\u2013218.","journal-title":"Am J Med Genet"},{"key":"BFbmt20175_CR5","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1182\/blood.V87.11.4894.bloodjournal87114894","volume":"87","author":"C Peters","year":"1996","unstructured":"Peters C, Balthazor M, Shapiro EG, King RJ, Kollman C, Hegland JD et al. Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. Blood 1996; 87: 4894\u20134902.","journal-title":"Blood"},{"key":"BFbmt20175_CR6","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1182\/blood.V91.7.2601","volume":"91","author":"C Peters","year":"1998","unstructured":"Peters C, Shapiro EG, Anderson J, Henslee-Downey PJ, Klemperer MR, Cowan MJ et al. Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group. Blood 1998; 91: 2601\u20132608.","journal-title":"Blood"},{"key":"BFbmt20175_CR7","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/sj.bmt.1704105","volume":"31","author":"G Souillet","year":"2003","unstructured":"Souillet G, Guffon N, Maire I, Pujol M, Taylor P, Sevin F et al. Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sources. Bone Marrow Transplant 2003; 31: 1105\u20131117.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt20175_CR8","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.bbmt.2015.02.011","volume":"21","author":"M Aldenhoven","year":"2015","unstructured":"Aldenhoven M, Jones SA, Bonney D, Borrill RE, Coussons M, Mercer J et al. Hematopoietic cell transplantation for mucopolysaccharidosis patients is safe and effective: results after implementation of international guidelines. Biol Blood Marrow Transplant 2015; 21: 1106\u20131109.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt20175_CR9","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1056\/NEJMoa032613","volume":"350","author":"SL Staba","year":"2004","unstructured":"Staba SL, Escolar ML, Poe M, Kim Y, Martin PL, Szabolcs P et al. Cord-blood transplants from unrelated donors in patients with Hurler's syndrome. N Engl J Med 2004; 350: 1960\u20131969.","journal-title":"N Engl J Med"},{"key":"BFbmt20175_CR10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/sj.bmt.1705718","volume":"40","author":"JJ Boelens","year":"2007","unstructured":"Boelens JJ, Wynn RF, O'Meara A, Veys P, Bertrand Y, Souillet G et al. Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure. Bone Marrow Transplant 2007; 40: 225\u2013233.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt20175_CR11","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/mt.2013.29","volume":"21","author":"FL Wilkinson","year":"2013","unstructured":"Wilkinson FL, Sergijenko A, Langford-Smith KJ, Malinowska M, Wynn RF, Bigger BW . Busulfan conditioning enhances engraftment of hematopoietic donor-derived cells in the brain compared with irradiation. Mol Ther 2013; 21: 868\u2013876.","journal-title":"Mol Ther"},{"key":"BFbmt20175_CR12","doi-asserted-by":"publisher","first-page":"3981","DOI":"10.1182\/blood-2012-09-455238","volume":"121","author":"JJ Boelens","year":"2013","unstructured":"Boelens JJ, Aldenhoven M, Purtill D, Ruggeri A, Defor T, Wynn R et al. Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning. Blood 2013; 121: 3981\u20133987.","journal-title":"Blood"},{"key":"BFbmt20175_CR13","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ymgme.2016.01.011","volume":"117","author":"A Ghosh","year":"2016","unstructured":"Ghosh A, Miller W, Orchard PJ, Jones SA, Mercer J, Church HJ et al. Enzyme replacement therapy prior to haematopoietic stem cell transplantation in Mucopolysaccharidosis Type I: 10year combined experience of 2 centres. Mol Genet Metab 2016; 117: 373\u2013377.","journal-title":"Mol Genet Metab"},{"key":"BFbmt20175_CR14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s10545-012-9500-3","volume":"36","author":"DH Wiseman","year":"2013","unstructured":"Wiseman DH, Mercer J, Tylee K, Malaiya N, Bonney DK, Jones SA et al. Management of mucopolysaccharidosis type IH (Hurler's syndrome) presenting in infancy with severe dilated cardiomyopathy: a single institution's experience. J Inherit Metab Dis 2013; 36: 263\u2013270.","journal-title":"J Inherit Metab Dis"},{"key":"BFbmt20175_CR15","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/bmt.2015.238","volume":"51","author":"S Ben-Barouch","year":"2016","unstructured":"Ben-Barouch S, Cohen O, Vidal L, Avivi I, Ram R . Busulfan fludarabine vs busulfan cyclophosphamide as a preparative regimen before allogeneic hematopoietic cell transplantation: systematic review and meta-analysis. Bone Marrow Transplant 2016; 51: 232\u2013240.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt20175_CR16","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.bbmt.2011.01.012","volume":"17","author":"A Ruggeri","year":"2011","unstructured":"Ruggeri A, Eapen M, Scaravadou A, Cairo MS, Bhatia M, Kurtzberg J et al. Umbilical cord blood transplantation for children with thalassemia and sickle cell disease. Biol Blood Marrow Transplant 2011; 17: 1375\u20131382.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt20175_CR17","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/bmt.2011.251","volume":"47","author":"HL Liu","year":"2012","unstructured":"Liu HL, Sun ZM, Geng LQ, Wang XB, Ding KY, Tang BI et al. Unrelated cord blood transplantation for newly diagnosed patients with severe acquired aplastic anemia using a reduced-intensity conditioning: high graft rejection, but good survival. Bone Marrow Transplant 2012; 47: 1186\u20131190.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt20175_CR18","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1016\/j.bbmt.2016.07.002","volume":"22","author":"Y Kuwatsuka","year":"2016","unstructured":"Kuwatsuka Y, Kanda J, Yamazaki H, Mori T, Miyamura K, Kako S et al. A comparison of outcomes for cord blood transplantation and unrelated bone marrow transplantation in adult aplastic anemia. Biol Blood Marrow Transplant 2016; 22: 1836\u20131843.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt20175_CR19","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3324\/haematol.2010.027839","volume":"96","author":"R Bizzetto","year":"2011","unstructured":"Bizzetto R, Bonfim C, Rocha V, Socie G, Locatelli F, Chan K et al. Outcomes after related and unrelated umbilical cord blood transplantation for hereditary bone marrow failure syndromes other than Fanconi anemia. Haematologica 2011; 96: 134\u2013141.","journal-title":"Haematologica"},{"key":"BFbmt20175_CR20","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s40262-014-0214-6","volume":"54","author":"R Admiraal","year":"2015","unstructured":"Admiraal R, van Kesteren C, Jol-van der Zijde CM, van Tol MJ, Bartelink IH, Bredius RG et al. Population pharmacokinetic modeling of Thymoglobulin((R)) in children receiving allogeneic-hematopoietic cell transplantation: towards improved survival through individualized dosing. Clin Pharmacokinet 2015; 54: 435\u2013446.","journal-title":"Clin Pharmacokinet"},{"key":"BFbmt20175_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/bmt.2015.196","volume":"51","author":"MS Cairo","year":"2016","unstructured":"Cairo MS, Tarek N, Lee DA, Delaney C . Cellular engineering and therapy in combination with cord blood allografting in pediatric recipients. Bone Marrow Transplant 2016; 51: 27\u201333.","journal-title":"Bone Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt20175.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt20175","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/bmt.2017.5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/bmt20175.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T19:14:31Z","timestamp":1648062871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt20175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,20]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["BFbmt20175"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2017.5","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,20]]},"assertion":[{"value":"30 September 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}